WASATCH ADVISORS INC 13D/13G Filings for Ligand Pharmaceuticals Incorporated (LGND)

WASATCH ADVISORS INC 13D and 13G filings for Ligand Pharmaceuticals Incorporated:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
1:24 pm
Sale		 2022-02-11 13G Ligand Pharmaceuticals Incorporated
LGND		 WASATCH ADVISORS INC 312,901
1.200%		 -1,561,001decrease
(-83.30%)		 Filing
2021-02-09
3:06 pm
Purchase		 2021-02-09 13G Ligand Pharmaceuticals Incorporated
LGND		 WASATCH ADVISORS INC 1,873,902
7.300%		 1,873,902increase
(New Position)		 Filing